Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Exchange Rate Effect (2016 - 2024)

Rockwell Medical's Exchange Rate Effect history spans 6 years, with the latest figure at -$1000.0 for Q4 2024.

  • For Q4 2024, Exchange Rate Effect fell 200.0% year-over-year to -$1000.0; the TTM value through Dec 2025 reached -$2000.0, up 60.0%, while the annual FY2024 figure was -$5000.0, 25.0% down from the prior year.
  • Exchange Rate Effect reached -$1000.0 in Q4 2024 per RMTI's latest filing, roughly flat from -$1000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $1000.0 in Q4 2023 to a low of -$3000.0 in Q1 2023.
  • Average Exchange Rate Effect over 3 years is -$1333.3, with a median of -$1000.0 recorded in 2022.
  • The largest YoY upside for Exchange Rate Effect was 50.0% in 2023 against a maximum downside of 200.0% in 2023.
  • A 3-year view of Exchange Rate Effect shows it stood at -$2000.0 in 2022, then surged by 150.0% to $1000.0 in 2023, then tumbled by 200.0% to -$1000.0 in 2024.
  • Per Business Quant, the three most recent readings for RMTI's Exchange Rate Effect are -$1000.0 (Q4 2024), -$1000.0 (Q3 2024), and -$3000.0 (Q2 2024).